Ipamorelin vs Sermorelin: GH Secretagogue Comparison

Ipamorelin vs Sermorelin: GH Secretagogue Comparison Ipamorelin vs Sermorelin compared: GH release mechanisms, evidence grades, dosing protocols, side effects, cost, and which growth hormone peptide is right for your research. Ipamorelin is a selective growth hormone releasing peptide (GHRP) that mimics ghrelin at the GHS receptor to trigger strong GH pulses with minimal cortisol and prolactin elevation. Sermorelin is a GHRH analog (first 29 amino acids of natural GHRH) that stimulates GH release through the GHRH receptor, more closely mimicking natural pituitary physiology. Both are used extensively in growth hormone optimization research and are frequently combined for synergistic effects. Class GHRP (Growth Hormone Releasing Peptide) GHRH analog (Growth Hormone Releasing Hormone) Mechanism Ghrelin/GHS receptor agonist GHRH receptor agonist Evidence Grade B+ Route Subcutaneous injection Typical Dose 200 - 300 mcg, 2-3x daily 200 - 500 mcg before bed Half-Life ~2 hours ~10-20 minutes GH Pulse Strength Strong, consistent pulses Moderate, physiological pulses Cortisol Impact Minimal (selective) None Prolactin Impact Minimal Appetite Effect Minimal (unlike GHRP-6) FDA History Not FDA-approved Previously FDA-approved (withdrawn 2008, commercial reasons) Desensitization Risk Low with proper cycling Very low Best Combined With CJC-1295 (GHRH analog) Ipamorelin or GHRP-2 (GHRP) Cost (research grade) $ $$ Strongest, cleanest GHRP with minimal side effects No significant cortisol or prolactin elevation Minimal appetite stimulation (unlike GHRP-6) Consistent, reproducible GH pulses Low desensitization risk with cycling Lower cost per dose than sermorelin Requires 2-3 injections per day for optimal results Works through a single pathway (GHS receptor only) No prior FDA approval history Best results require combination with a GHRH analog May cause mild water retention in some users Most physiological GH stimulation pattern Previously FDA-approved (strong safety history) No cortisol, prolactin, or appetite effects Very low desensitization risk Once-daily dosing (before bed) is adequate Well-studied in clinical settings Shorter half-life (~10-20 min) limits GH pulse duration Lower peak GH release compared to GHRPs Higher cost per dose than ipamorelin Effectiveness decreases with age and pituitary decline FDA approval was withdrawn (commercial, not safety reasons) Choose Ipamorelin if: You want the strongest GH pulse per injection with the cleanest side effect profile among GHRPs. Ipamorelin is ideal for researchers seeking robust GH release without cortisol/prolactin interference. It is best combined with a GHRH analog (CJC-1295 or sermorelin itself) for maximum synergy. Choose Sermorelin if: You prefer the most physiological approach to GH stimulation with the strongest regulatory safety history. Sermorelin more closely mimics natural GH secretion and is ideal for anti-aging, recovery, and sleep quality research. Its once-daily bedtime dosing is also more convenient. Combine both if: Maximum GH optimization is the goal. The GHRP + GHRH combination (ipamorelin + sermorelin or CJC-1295) is the gold standard in peptide-based GH research, producing synergistic release greater than either compound alone. Ipamorelin tends to produce stronger, more consistent GH pulses per injection with fewer side effects. Sermorelin more closely mimics natural GHRH physiology but produces somewhat lower peak GH levels. Many researchers combine both for synergistic GH release through complementary receptor pathways. Yes, combining ipamorelin (GHRP) with sermorelin (GHRH analog) is a well-established protocol. They work through different receptors, creating synergistic GH release greater than either alone. This is considered the gold standard for peptide-based GH optimization. Ipamorelin is notable for minimal cortisol elevation, no significant prolactin increase, and minimal appetite stimulation. Sermorelin side effects include injection site reactions, facial flushing, headache, and occasional dizziness. Both are well-tolerated compared to exogenous HGH or other GHRPs like GHRP-6. Verified Research Suppliers Research-grade peptides are available from verified suppliers listed on our Vendor Comparison page. All listed vendors meet cGMP certification and third-party testing standards. Related Tools & Resources Related Resources